19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivo

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 5, 2010, Pages 935-941

  He, Yan ^a   Jiang, Yang ^a   Li, Ying Jie ^a   Liu, Xing Han ^a   Zhang, Lei ^a   Liu, Li Juan ^a   Shi, Hang ^a   Li, Hui Ning ^a   Ma, Yong Cu ^a   Jin, Xiao Ming ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Animal models; Cell and molecular biology; Gastric cancer: basic experimental study

Indexed keywords

19 PEPTIDE; GLUE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN; PROTEIN KINASE B; SEPHADEX; TUMSTATIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CASPASE 9; GELATINASE A; PEPTIDE FRAGMENT; PROTEIN BAD; AUTOANTIGEN; COLLAGEN TYPE 4; PTEN PROTEIN, HUMAN; TYPE IV COLLAGEN ALPHA3 CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIUM; CANCER INHIBITION; CANCER INVASION; CANCER SIZE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL VIABILITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GASTRIC CARCINOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SEROSA; SOLID TUMOR; STOMACH CARCINOMA; TUMOR VOLUME; UMBILICAL VEIN; WESTERN BLOTTING; ANGIOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METASTASIS INHIBITION; NEUTROPHIL; ORTHOTOPIC TRANSPLANTATION; PROTEIN PHOSPHORYLATION; STOMACH ADENOCARCINOMA; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUNEL ASSAY; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA; CELL MOTION; DRUG EFFECTS; DRUG SCREENING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; STOMACH NEOPLASMS; TIME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOANTIGENS; BLOTTING, WESTERN; CARCINOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN TYPE IV; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; STOMACH NEOPLASMS; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77951735576     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06209.x     Document Type: Article

References (30)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nat. Med. 1995 1 : 27 31.
2. Folkman J. Clinical applications of research on angiogenesis. N. Engl. J. Med. 1995 333 : 1757 1763.
3. Bischoff J. Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell. Biol. 1995 5 : 69 74.
4. Folkman J, Shing Y. Angiogenesis. Biol. Chem. 1992 267 : 10931 10934.
5. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 1971 285 : 1182 1186.
6. Denekamp J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol. 1993 66 : 81 96.
7. Tabruyn SP, Griffioen AW. Molecular pathways of angiogenesis inhibition. Biochem. Biophys. Res. Commun. 2007 355 : 1 5.
8. Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. Biol. Chem. 1988 263 : 13374 13380.
9. Maeshima Y, Colorado PC, Torre A. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. Biol. Chem. 2000 275 : 21340 21348.
10. Kamphaus GD, Colorado PC, Panka DJ. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. Biol. Chem. 2000 275 : 1209 1215.
11. Monboisse JC, Garnotel R, Bellon G. The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes. J. Biol. Chem. 1994 269 : 25475 25482.
12. Wang SJ, Liu Y, Lin XS, Fu X, Xu JY, Liu XH. Cloning and biological activity of anti-tumor peptide of tumstatin (in Chinese with English abstract). Chin. J. Biochem. Mol. Biol. 2005 21 : 322 328.
13. Chen YL, Wei PK, Xu L, Su XM. Nude mouse model of human gastric carcinoma metastasis constructed by orthotopic transplantation using organism glue paste technique. Ai Zheng 2005 24 : 246 248.
14. Jun KF, Tian X, Jin FG et al. Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor. Biochem. Biophys. Res. Commun. 2008 374 : 198 203.
15. Liu G, Sun Y, Li Z et al. Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem. Biophys. Res. Commun. 2008 370 : 651 656.
16. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Meth. 1995 184 : 39 51.
17. Hanaichi T, Sato T, Iwamoto T, Malavasi-Yamashiro J, Hoshino M, Mizuno N. A stable lead stain by modification of Sato's method. J. Electron. Microsc. (Tokyo) 1986 35 : 304 306.
18. Tian YY, Leung WN, Yue KM, Mak N. Cell death induced by MPPa-PDT in prostate carcinoma in vitro and in vivo. Biochem. Biophys. Res. Commun. 2006 348 : 413 420.
19. Li Y-J, Sun L-C, He Y et al. The anti-tumor properties of two tumstatin peptide fragments in human gastric carcinoma. Acta Pharmacol. Sin. 2009 30 : 1307 1315.
20. Shahan TA, Ziaie Z, Pasco S. Identification of CD47/integrin-associated protein and avb3 as two receptors for the α3(IV) chain of type IV collagen on tumor cells. Cancer Res. 1999 59 : 4584 4590.
21. Han J, Ohno N, Pasco S. A cell binding domain from the a3 chain of type IV collagen inhibits proliferation of melanoma cells. Biol. Chem. 1997 272 : 20395 20401.
22. Chen HC, Guan JL. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 1994 91 : 10148 10152.
23. Borlado LR, Redondo C, Alvarez B et al. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J. 2000 14 : 895 903.
24. Kim JE, Chen J. Cytoplasmic-nuclear shuttling of FKBP12- rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proc. Natl. Acad. Sci. USA 2000 97 : 14340 14345.
25. Herbert J, Fahraeus R, Prescott A. Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E. Curr. Biol. 2000 10 : 793 796.
26. Yamada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell. Sci. 2007 114 : 2375 2382.
27. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr. Opin. Cell. Biol. 1997 9 : 701 706.
28. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell. Biol. 1996 134 : 793 799.
29. Owens LV, Xu L, Craven RJ et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 1995 55 : 2752 2755.
30. Stambolic V, Suzuki A, de la Pompa JL et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998 95 : 29 39.